.
VBIV financial statements
* Numbers in thousands
Year |
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
Capitalization * |
120 447 | 69 934 | 49 964 | 79 120 | 114 165 | 176 193 | 107 662 | 166 030 | 765 153 | 410 177 | 338 396 |
EV * |
82 787 | 21 468 | 12 252 | 52 360 | 93 839 | 121 637 | 62 419 | 137 304 | 688 601 | 318 602 | 318 602 |
Stock price $ |
24.8 | 14 | 10 | 14.8 | 3.8 | 3.99 | 1.64 | 1.39 | 3.26 | 1.6 | 1.32 |
Number of shares * |
4 857 | 4 995 | 4 996 | 5 346 | 30 044 | 44 159 | 65 648 | 119 446 | 234 709 | 256 360 | 256 360 |
EPS |
-2,71 | -1,33 | -0,92 | -12,33 | -0,77 | -0,88 | -0,97 | -0,46 | -0,20 | -0,27 | -0,27 |
Revenue * |
0 | 0 | 0 | 0 | 548 | 865 | 3 355 | 2 221 | 1 061 | 631 | 631 |
Net income * |
-13 155 | -6 653 | -4 594 | -65 924 | -23 205 | -38 995 | -63 600 | -54 813 | -46 230 | -69 753 | -69 753 |
Operating profit * |
-13 612 | -7 380 | -5 290 | -4 137 | -24 850 | -37 280 | -60 408 | -46 107 | -43 617 | -68 032 | -68 032 |
Total liabilities * |
710 | 240 | 249 | 277 | 21 023 | 25 869 | 39 472 | 33 946 | 37 667 | 66 394 | 66 394 |
Net debt * |
-37 660 | -48 466 | -37 712 | -26 760 | -20 326 | -54 556 | -45 243 | -27 909 | -76 552 | -91 575 | -91 575 |
Total assets * |
185 284 | 175 617 | 157 173 | 81 222 | 104 754 | 145 656 | 137 605 | 122 201 | 209 372 | 210 276 | 210 276 |
Equity * |
184 574 | 175 377 | 156 924 | 80 945 | 83 731 | 119 787 | 98 133 | 88 255 | 171 705 | 143 882 | 143 882 |
Cash and investments * |
58 193 | 48 470 | 37 712 | 39 429 | 32 282 | 67 694 | 59 270 | 44 213 | 119 101 | 121 694 | 121 694 |
Over the past 10 years, the maximum capitalization of VBI Vaccines Inc. is 765 153, the minimum is 49 964. Maximum net income 0, Minimum net income -69 753. The maximum price of VBIV shares is 24.8, the minimum price is 1.39.
.
VBIV valuation
Year |
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-9,16 | -10,51 | -10,88 | -1,20 | -4,92 | -4,52 | -1,69 | -3,03 | -16,55 | -5,88 | -4,85 |
P/B |
0,65 | 0,40 | 0,32 | 0,98 | 1,36 | 1,47 | 1,10 | 1,88 | 4,46 | 2,85 | 2,35 |
P/S |
0,00 | 0,00 | 0,00 | 0,00 | 208,33 | 203,69 | 32,09 | 74,75 | 721,16 | 650,04 | 536,29 |
E/P |
-11% | -10% | -9% | -83% | -20% | -22% | -59% | -33% | -6% | -17% | -21% |
P/FCF |
-8,42 | -8,19 | -7,25 | -29,03 | -5,98 | -5,50 | -2,09 | -3,17 | -15,92 | -10,33 | -8,52 |
.
VBIV profitability
Year |
2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
ROE |
-7% | -4% | -3% | -81% | -28% | -33% | -65% | -62% | -27% | -48% | |
ROA |
-7% | -4% | -3% | -81% | -63% | -53% | -89% | -93% | -32% | -48% | |
ROIC |
-7% | -4% | -3% | -5% | -26% | -28% | -53% | -50% | -23% | -38% |